|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
European Association for The Study of The
Liver, European Organisation for Research and Treatment of Cancer,
. EASL-EORTC clinical practice guidelines: Management of
hepatocellular carcinoma. J Hepatol. 56:908–943. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pardee AD and Butterfield LH:
Immunotherapy of hepatocellular carcinoma: Unique challenges and
clinical opportunities. Oncoimmunology. 1:48–55. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tsuchiya N, Sawada Y, Endo I, Uemura Y and
Nakatsura T: Potentiality of immunotherapy against hepatocellular
carcinoma. World J Gastroenterol. 21:10314–10326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hernandez-Gea V, Toffanin S, Friedman SL
and Llovet JM: Role of the microenvironment in the pathogenesis and
treatment of hepatocellular carcinoma. Gastroenterology.
144:512–527. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wan S, Zhao E, Kryczek I, Vatan L,
Sadovskaya A, Ludema G, Simeone DM, Zou W and Welling TH:
Tumor-associated macrophages produce interleukin 6 and signal via
STAT3 to promote expansion of human hepatocellular carcinoma stem
cells. Gastroenterology. 147:1393–1404. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ruffell B, Affara NI and Coussens LM:
Differential macrophage programming in the tumor microenvironment.
Trends Immunol. 33:119–126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gordon S: Alternative activation of
macrophages. Nat Rev Immunol. 3:23–35. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Locati M, Mantovani A and Sica A:
Macrophage activation and polarization as an adaptive component of
innate immunity. Adv Immunol. 120:163–184. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sica A and Mantovani A: Macrophage
plasticity and polarization: In vivo veritas. J Clin Invest.
122:787–795. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wynn TA and Vannella KM: Macrophages in
tissue repair, regeneration, and fibrosis. Immunity. 44:450–462.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yeung OW, Lo CM, Ling CC, Qi X, Geng W, Li
CX, Ng KT, Forbes SJ, Guan XY, Poon RT, et al: Alternatively
activated (M2) macrophages promote tumour growth and invasiveness
in hepatocellular carcinoma. J Hepatol. 62:607–616. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yao RR, Li JH, Zhang R, Chen RX and Wang
YH: M2-polarized tumor-associated macrophages facilitated migration
and epithelial-mesenchymal transition of HCC cells via the
TLR4/STAT3 signaling pathway. World J Surg Oncol. 16:92018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cannons JL, Tangye SG and Schwartzberg PL:
SLAM family receptors and SAP adaptors in immunity. Annu Rev
Immunol. 29:665–705. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Veillette A: Immune regulation by SLAM
family receptors and SAP-related adaptors. Nat Rev Immunol.
6:56–66. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Calpe S, Wang N, Romero X, Berger SB,
Lanyi A, Engel P and Terhorst C: The SLAM and SAP gene families
control innate and adaptive immune responses. Adv Immunol.
97:177–250. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang N, Keszei M, Halibozek P, Yigit B,
Engel P and Terhorst C: Slamf6 negatively regulates autoimmunity.
Clin Immunol. 173:19–26. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang N, Halibozek PJ, Yigit B, Zhao H,
O'Keeffe MS, Sage P, Sharpe A and Terhorst C: Negative regulation
of humoral immunity due to interplay between the SLAMF1, SLAMF5,
and SLAMF6 Receptors. Front Immunol. 6:1582015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Flaig RM, Stark S and Watzl C: Cutting
edge: NTB-A activates NK cells via homophilic interaction. J
Immunol. 172:6524–6527. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bottino C, Falco M, Parolini S, Marcenaro
E, Augugliaro R, Sivori S, Landi E, Biassoni R, Notarangelo LD,
Moretta L and Moretta A: NTB-A [correction of GNTB-A], a novel
SH2D1A-associated surface molecule contributing to the inability of
natural killer cells to kill Epstein-Barr virus-infected B cells in
X-linked lymphoproliferative disease. J Exp Med. 194:235–246. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Marcq I, Nyga R, Cartier F, Amrathlal RS,
Ossart C, Ouled-Haddou H, Ghamlouch H, Galmiche A, Chatelain D,
Lamotte L, et al: Identification of SLAMF3 (CD229) as an inhibitor
of hepatocellular carcinoma cell proliferation and tumour
progression. PLoS One. 8:e829182013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bouhlal H, Ouled-Haddou H, Debuysscher V,
Singh AR, Ossart C, Reignier A, Hocini H, Fouquet G, Al Baghami M,
Eugenio MS, et al: RB/PLK1-dependent induced pathway by SLAMF3
expression inhibits mitosis and control hepatocarcinoma cell
proliferation. Oncotarget. 7:9832–9843. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang N, Satoskar A, Faubion W, Howie D,
Okamoto S, Feske S, Gullo C, Clarke K, Sosa MR, Sharpe AH and
Terhorst C: The cell surface receptor SLAM controls T cell and
macrophage functions. J Exp Med. 199:1255–1264. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fouquet G, Marcq I, Debuysscher V, Bayry
J, Rabbind Singh A, Bengrine A, Nguyen-Khac E, Naassila M and
Bouhlal H: Signaling lymphocytic activation molecules Slam and
cancers: Friends or foes? Oncotarget. 9:16248–16262. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chatterjee M, Kis-Toth K, Thai TH,
Terhorst C and Tsokos GC: SLAMF6-driven co-stimulation of human
peripheral T cells is defective in SLE T cells. Autoimmunity.
44:211–218. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chatterjee M, Rauen T, Kis-Toth K,
Kyttaris VC, Hedrich CM, Terhorst C and Tsokos GC: Increased
expression of SLAM receptors SLAMF3 and SLAMF6 in systemic lupus
erythematosus T lymphocytes promotes Th17 differentiation. J
Immunol. 188:1206–1212. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
van Driel B, Wang G, Liao G, Halibozek PJ,
Keszei M, O'Keeffe MS, Bhan AK, Wang N and Terhorst C: The cell
surface receptor Slamf6 modulates innate immune responses during
Citrobacter rodentium-induced colitis. Int Immunol. 27:447–457.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yigit B, Halibozek PJ, Chen SS, O'Keeffe
MS, Arnason J, Avigan D, Gattei V, Bhan A, Cen O, Longnecker R, et
al: A combination of an anti-SLAMF6 antibody and ibrutinib
efficiently abrogates expansion of chronic lymphocytic leukemia
cells. Oncotarget. 7:26346–26360. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cannons JL, Yu LJ, Hill B, Mijares LA,
Dombroski D, Nichols KE, Antonellis A, Koretzky GA, Gardner K,
Schwartzberg PL, et al: SAP regulates T(H)2 differentiation and
PKC-theta-mediated activation of NF-kappaB. Immunity. 21:693–706.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mussbacher M, Salzmann M, Brostjan C,
Hoesel B, Schoergenhofer C, Datler H, Hohensinner P, Basílio J,
Petzelbauer P, Assinger A and Schmid JA: Cell type-specific roles
of NF-κB linking inflammation and thrombosis. Front Immunol.
10:852019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Crowe NY, Coquet JM, Berzins SP,
Kyparissoudis K, Keating R, Pellicci DG, Hayakawa Y, Godfrey DI and
Smyth MJ: Differential antitumor immunity mediated by NKT cell
subsets in vivo. J Exp Med. 202:1279–1288. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang X, Goncalves R and Mosser DM: The
isolation and characterization of murine macrophages. Curr Protoc
Immunol. Nov 15–2008.(Epub ahead of print). doi:
10.1002/0471142735.im1401s83. View Article : Google Scholar
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)). Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sauzay C, Petit A, Bourgeois AM, Barbare
JC, Chauffert B, Galmiche A and Houessinon A: Alpha-foetoprotein
(AFP): A multi-purpose marker in hepatocellular carcinoma. Clin
Chim Acta. 463:39–44. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mantovani A, Sozzani S, Locati M, Allavena
P and Sica A: Macrophage polarization: Tumor-associated macrophages
as a paradigm for polarized M2 mononuclear phagocytes. Trends
Immunol. 23:549–555. 2002. View Article : Google Scholar : PubMed/NCBI
|
